384 related articles for article (PubMed ID: 18598204)
1. Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Chem Lab Med; 2008; 46(5):667-73. PubMed ID: 18598204
[TBL] [Abstract][Full Text] [Related]
2. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
3. The multiplicative interactions of leukocyte counts with some other risk factors enhance the prognostic value for coronary artery disease.
Rasouli M; Nesarhosseini V; Kiasari AM; Arab S; Shariati R; Kazemi D; Daneshpour N; Heidari S
Cardiol J; 2011; 18(3):246-53. PubMed ID: 21660913
[TBL] [Abstract][Full Text] [Related]
4. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
5. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
[TBL] [Abstract][Full Text] [Related]
6. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
Rasouli M; Kiasari AM
Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
[TBL] [Abstract][Full Text] [Related]
7. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
8. [Association between lipoprotein(a) and coronary artery disease].
Wang G; Li YF
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):618-20. PubMed ID: 21055285
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
[TBL] [Abstract][Full Text] [Related]
10. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
Gupta R; Vasisht S; Bahl VK; Wasir HS
Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
[TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
12. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
13. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.
Kumakura H; Fujita K; Kanai H; Araki Y; Hojo Y; Kasama S; Iwasaki T; Ichikawa S; Nakashima K; Minami K
J Atheroscler Thromb; 2015; 22(4):344-54. PubMed ID: 25296963
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.
Bandara EM; Ekanayake S; Wanigatunge CA; Kapuruge A
BMC Cardiovasc Disord; 2016 Nov; 16(1):213. PubMed ID: 27825299
[TBL] [Abstract][Full Text] [Related]
16. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
[TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein (a) as a risk factor for coronary artery disease in women and elderly patients].
Serdar A; Yeşilbursa D; Serdar Z
Anadolu Kardiyol Derg; 2001 Dec; 1(4):259-63; AXV-XVI. PubMed ID: 12101835
[TBL] [Abstract][Full Text] [Related]
19. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
20. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
Shahid HS; Kurdi MI; Zohair AA
Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
